Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1
Stanislaw R Burzynski,
Gregory S Burzynski,
Tomasz J Janicki,
Samuel W Beenken
Burzynski S, Burzynski G, Janicki T, Beenken S. Outcomes in Four Children with Persistent,
Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and
AS2-1 Neurol Neurosci. 2022; 3(3):1-9